VERA THERAPEUTICS INC (VERA) Stock Balance Sheet
NASDAQ:VERA - Nasdaq - US92337R1014 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 27.26M | 160.72M | 43.50M | 79.70M | 53.70M | |||
| Marketable Securities | 326.05M | 115.03M | 71.20M | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | 100.00K | |||
| Other Current Assets | 10.82M | 11.31M | 11.00M | 2.90M | 500.00K | |||
| Total Current Assets | 364.13M | 172.02M | 125.70M | 82.50M | 54.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.29M | 3.04M | 5.20M | N/A | 0.00 | |||
| Investments And Advances | N/A | 11.00K | 100.00K | 900.00K | N/A | |||
| Other Non-Current Assets | 140.00K | 471.00K | 500.00K | 300.00K | 300.00K | |||
| Total Non-Current Assets | 4.43M | 3.52M | 5.70M | 1.20M | 300.00K | |||
| TOTAL ASSETS | 368.56M | 175.55M | 131.40M | 83.70M | 54.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 21.58M | 11.19M | 13.60M | 5.90M | 500.00K | |||
| Accounts Payable | 4.60M | 11.12M | 12.00M | 1.40M | 900.00K | |||
| Other Current Liabilities | 286.00K | N/A | 0.00 | 400.00K | 1.00M | |||
| Total Current Liabilities | 26.46M | 22.30M | 25.60M | 7.70M | 2.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 50.47M | 49.88M | 24.80M | 4.90M | 0.00 | |||
| Other Non-Current Liabilities | 2.57M | 1.68M | 4.10M | 1.50M | 1.90M | |||
| Total Non-Current Liabilities | 53.04M | 51.56M | 28.90M | 6.50M | 1.90M | |||
| TOTAL LIABILITIES | 79.50M | 73.86M | 54.50M | 14.20M | 4.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -417.82M | -309.10M | -213.10M | -124.10M | -91.40M | |||
| Additional Paid In Capital | 706.83M | 410.74M | 290.00M | 193.60M | 2.10M | |||
| Common Shares | 55.00K | 44.00K | 0.00 | 0.00 | 139.60M | |||
| Shares Outstanding | 55.03M | 44.45M | 27.80M | 21.30M | 20.50M | |||
| Tangible Book Value per Share | 5.25 | 2.29 | 2.77 | 3.27 | -4.36 | |||
| Total Shareholders' Equity | 289.06M | 101.69M | 76.90M | 69.60M | 50.20M | |||
| TOTAL LIABILITIES AND EQUITY | 368.56M | 175.55M | 131.40M | 83.70M | 54.60M | |||
| Statistics | ||||||||
| Debt/Equity | 0.17 | 0.49 | 0.32 | 0.07 | N/A | |||
| Current Ratio | 13.76 | 7.71 | 4.91 | 10.71 | 22.63 | |||
| Return On Assets (ROA) | -36.46% | -54.68% | -67.78% | -38.96% | -97.82% | |||
| Return On Equity (ROE) | -46.49% | -94.40% | -115.81% | -46.85% | -106.39% | |||
All data in USD , ROIC based on taxRate of 0.21